logo
episode-header-image
Mar 2023
40m 32s

S4 E9: "Do The Maths" song; JOMT intervi...

NB Medical Education
About this episode

Welcome to the Hot Topics Podcast with host, Dr Neal Tucker.

In this bumper edition we have the next in our Just One More Thing series. We interview Dr Sam Merriel in collaboration with Prostate Cancer UK, talking about what we need to know in the world of prostate cancer. Should we be screening? Do we need to think beyond PSA? Does new technology change our approach?

In news we look at the latest RCGP data on workload and whether GPs will strike, while in research we have a BJGP paper on why antimicrobial stewardship interventions may not have the impact in real life that they do in trials, a BJGP analysis of nitrofurantoin (and other antibiotic) failure in men with UTI, and a NEJM paper testing whether thiazides help renal stones.

References:

Free on demand NB Clinic with Prostate Cancer UK, March 2022
PCUK Resources for Health Professionals
PCUK Resources for Delivering the PCN DES
PCUK 30 second Risk Checker for Patients
Research discussed by Sam Merriel
...Lifetime risk of PCa by major ethnic group in England
...Family history risk for PCa
...Genetic risk scores for PCa in patient with LUTS
BJGP Implementing Antimicrobial Stewardship in GP
BJGP Nitrofurantoin failure in men with UTI
NEJM Hydrochlorthiazide and renal stones



Up next
Jul 4
S6 E12: Anti-Ds for Insomnia; SSRIs & Hypotension; Cancer Cures
Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. While everyone tries to unpick the new NHS 10-year plan, we focus on the here and now with three new pieces of research.We kick off with two gems in the BJGP - first, examining whether anti-depressants actuall ... Show More
23m 41s
Jun 6
S6 E11: Exercise & Colorectal Cancer; IBS & Amitriptyline; SGLT2i & Liver Disease
Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we look at three new pieces of research with implications for general practice.Firstly, can exercise prevent the recurrence of colorectal cancer? Short answer, yes. But how much exercise did y ... Show More
26m 15s
May 9
S6 E10: GPs vs PTSD; GLP1s vs PAD; Exercise vs Cancer
Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this edition, we look at three new pieces of research.First, in the BMJ, a paper exploring whether a GP-led psychological intervention can help PTSD symptoms in our patients after ICU. Could this also be su ... Show More
31m 50s
Recommended Episodes
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Sep 2024
Dr. Vogl discusses the role of genetic testing for prostate cancer
This EAU podcast has been developed with financial support from Pfizer Inc for healthcare professionals based in the EU and UK. The content discussed here was up to date at the time of recording in June 2024 and may not be suitable in your local market. The EAU has retained full ... Show More
12m 51s
Nov 2024
Dr. van den Bergh and Dr. Beyer discuss the impact of urology on public health
In 'Episode 2' of the series on "Exploring urology: A roadmap for medical students", Dr. Roderick Van Den Bergh (NL) and Dr. Katharina Beyer (NL) speak about "The impact of urology on public health". Dr. Van Den Bergh and Dr. Beyer discuss the importance of urology in p ... Show More
17m 8s
Nov 2024
Olympian Sir Chris Hoy wants more tests for prostate cancer - should it happen?
Olympic cyclist Sir Chris Hoy is calling for more prostate cancer testing after he was diagnosed with terminal cancer. Prostate cancer can often present without symptoms, and for people like Sir Chris, this can mean it isn't diagnosed until it has spread and become incurable. Unl ... Show More
27m 53s
May 2023
Dr. Jones discusses clinical fracture incidence in mHSPC
In this podcast, Prof. Igor Tsaur (DE), chief editor of the UROONCO PCa editorial board talks with Dr. Craig Jones (GB),  from Salford Royal and Christie Hospitals, about his recent presentation at AUA2023, "Clinical fracture incidence in metastatic hormone-sensitive prostate can ... Show More
6m 16s
Jul 2024
#310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Ted Schaeffer is an internationally recognized urologist specializing in prostate cancer and a returning guest on The Drive. In this episode, Ted pr ... Show More
47m 53s
Dec 2024
Kidney cancer - Take home messages for 2024
The UROONCO RCC editorial board chief editor Dr. Carmen Mir, and associate editors Dr. Teele Kuusk and Dr. Riccardo Bertolo share highlights of the important kidney cancer developments for 2024.  They summarise the results on several important trials such as FASTRACK, ZIRCON, KEY ... Show More
13m 51s
Mar 2022
Episode 008: Metastatic Cancer of “Origin TBD”
Not to be confused with “carcinoma of unknown primary,” in this episode of metastatic disease of “origin TBD”, we discuss the workup of a mass noted incidentally on imaging. This is a very high yield topic often faced on solid oncology consults! Major Points Covered:Mass found in ... Show More
28m 22s
Apr 29
BOSS update: Oesophageal cancer with Massimiliano Di Pietro (bonus episode)
Hot off the press: The BOSS (Barrett’s Oesophagus Surveillance Versus Endoscopy at Need Study) randomised control study. Is surveillance really not affecting survival in oesophageal cancer patients? To put things into perspective, we asked Massimiliano Di Pietro, UEG Talks podcas ... Show More
22m 45s
Apr 29
Tackling bias in health
Bias in the way medical research is carried out means that new medicines for diseases such as cancer – as well as the tools used to diagnose patients with some conditions – are disproportionally tested on people of European heritage. This can lead to those not represented in the ... Show More
23m 18s